Propranolol directly interacts with the ryanodine receptor, altering its binding and channel activities depending on its conformational state, suggesting its potential utility as a conformational probe.
No takes yet. Share an insight, caveat, or question.
Hypothesis-generating for propranolol as RyR probe in models; clinical translation in humans remains untested.
Zchut et al. (1996) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: